GlaxoSmithKline logo

Quarterly results

We announce our results on a quarterly basis.

This section contains details of our results announcements, to view and download, along with links to related webcasts and presentations.

Results from previous years are archived by date, and can be accessed from the tabs below.


Fourth Quarter 2011

7 February 2012

 

Third Quarter 2011

26 October 2011

Q3 results 2011

GSK announces Q3 2011 results

  • Underlying sales growth of 6% and reported sales growth of 3%
  • EPS before major restructuring 28.5p, dividend 17p (up 6%)
  • Strong contribution from Japan: sales +57%




Second Quarter 2011

26 July 2011

Andrew Witty

GSK announces Q2 2011 results

  • Q2 reported sales -2%
  • EPS before major restructuring* 25p
  • Underlying sales growth of 5%
  • Increased pipeline visibility and dividend of 16p, up 7%



First Quarter 2011

27 April 2011

Andrew Witty, CEO

GSK announces Q1 results for 2011

  • Reported sales -10%, underlying sales +4%
  • EPS before major restructuring 32.2p (+9%), dividend 16p (+7%)



GSK CEO Andrew Witty

Share price

LSE
1,415p
-1.50

06 Feb 2012 09:30 am BST
NYSE
44.85
0.45

03 Feb 2012 04:00 pm EDT
London Stock Exchange price updated every 15 minutes. Provided by Investis Limited.